1 |
Pugliese, G., Pricci, F., Locuratolo, N., Romeo, G., Romano, G., Giannini, S., Cresci, B., Galli, G., Rotella, C. M., Di Mario, U. (1996). Increased activity of the insulin-like growth factor system in mesangial cell cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production. Diabetologia 39, 775-784
DOI
ScienceOn
|
2 |
Pugliese, G., Pricci, F., Romeo, G., Pugliese, F., Mene, P., Giannini, S., Cresci, B., Galli, G., Rotella, C. M., Vlassara, H., Di Mario, U. (1997). Upregulation ofmesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes 46, 1881-1887
DOI
ScienceOn
|
3 |
Shinohara, M., Thomalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., Brownlee, M. (1998). Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest. 101, 1142-1147
DOI
ScienceOn
|
4 |
Skolnik, E. Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., Vlassara, H. (1991). Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodeling and diabetic nephropathy. J. Exp. Med. 174, 931-939
DOI
ScienceOn
|
5 |
Soulis, T., Cooper, M. E., Sastra, S., Thallas, V., Panagiotopoulos, S., Bjerrum, O. J., Jerurns, G. (1997). Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rat. Diabetologia 40, 1141-1151
DOI
ScienceOn
|
6 |
Stitt, A. W., Chakravarthy, U., Archer, D. B., Gardiner, T. A. (1995). Increased endocytosis in retinal vascular endothelial cells grown in high glucose medium is modulated by inhibitors of nonenzymatic glycosylation. Diabetologia 38, 1271-1275
DOI
ScienceOn
|
7 |
Thornally, P. J. (1998). Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell. Mol. Biol. 44, 1013-1023
|
8 |
Tilton, R. G., Chang, C., Hasan, K. S., Smith, S. R., Petrash, M., Misko, T. P., Moore, M. M., Currie, M. G., Corbett, J. A., McDaniel, M. L., Williamson, J. R. (1993). Prevention of diabetic vascular dysfunction by guanidine. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42, 221-232
DOI
ScienceOn
|
9 |
Tomino, Y., Wang, L. N., Fukui, M., Yaguchi, Y, Koide, H. (1991). Glomerular nonenzymatic glycosylation and lipid peroxide are increased in the early phase of streptozotocininduced diabetic rats prior to major histopathologic alterations. Nephron 59, 632-636
DOI
|
10 |
Trachtman, H., Futterweit, S., Singhal, P. (1995). Nitric oxide modulates the synthesis of extracellulaar matrix proteins in cultured rat mesangial cells. Biochem. Biophys. Res. Comm. 207, 120-125
DOI
ScienceOn
|
11 |
Trachtman, H., Futterwit, S., Crimmins, D. L. (1997). High glucose inhibits nitric oxide production in cultured rat mesangial cells. J. Am. Soc. Nephrol. 8, 1276-1282
|
12 |
Tsang, V. C. W., Peralta, J. M., Simons, A. R. (1983). Enzymelinked immunoelectro- transfer blot technique for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods in Enzymol. 92, 377-391
DOI
|
13 |
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., Steffer, M. (1994). Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc. Natl. Acad. Sci. USA 91, 11704-11708
|
14 |
Yu, P. H., Zuo, D.M. (1997). Aminoguanidine inhibits semicarbazidesensitive amine oxidase activity: Implications for advanced glycation and diabetic compliations. Diabetologia 40, 1243-1250
DOI
ScienceOn
|
15 |
Ziyadeh, F. N., Han, D. C. (1997). Involvement of transfonning growth factor- and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int. 52 [Suppl 60], S7-S11.
|
16 |
Miyata, S., Monnier, V. (1992). Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. J. Clin. Invest. 89, 1102-1112
DOI
|
17 |
Yang, C.-W., Hatteri, M., Vlassara, H., He, C.-J., Carome, M. A., Yamato E., Elliot S., Striker G. E., Striker L. J. (1995). Overex-pression of transforming growth factor- mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J. Am. Soc. Nephrol. 5, 1610-1617
|
18 |
Giardino, I., Edelstein, D., Brownlee, M. (1994). Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. a model for intracellular glycosylation in diabetes. J. Clin. Invest. 94, 110-117
DOI
|
19 |
Kolm-Litty, V, Sauer, U., NerJich, A., Lehmann, R., Schleicher, E. D. (1998). High glucose-induced transforming growth factor beta 1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J. Clin. Invest. 101, 160-169
DOI
ScienceOn
|
20 |
Steffes, M. W., Osterby, R, Chavers, B., Mauer, S. M. (1989). Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38, 1077-1081
DOI
ScienceOn
|
21 |
Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Ann. Rev. Med. 46, 223-224
DOI
ScienceOn
|
22 |
Yang, C.-W., Vlassara, H., Peten, E. P., He, C.-J., Striker, G. E., Striker L. J. (1994). Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc. Natl. Acad. Sci. USA 91, 9436-9440
|
23 |
Yang, C.-W., Vlassara, H., Striker, G. E., Striker, L. J. (1995). Administration of AGE in vivo induces genes implicated in diabetic glomerulosclerosis. Kidney Int. 47 [Suppl 49], S55-S58
|
24 |
Bleyer, A. J., Fumo, P., Snipes, E. R., Goldfarb, S., Simmons, D. A., Ziyadeh, F. N. (1994). Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubules. Kidney Int. 42, 659-666
|
25 |
Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
DOI
ScienceOn
|
26 |
Brownlee, M., Cerami, A., Vlassara, H. (1988). Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321
DOI
ScienceOn
|
27 |
Chornczynski, P., Sacchi, N. (1989). Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156-160
|
28 |
Corbett, J. A., McDaniel, M. L. (1996). Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods in Enzymol. 268, 398-408
DOI
|
29 |
Craven, P. A., Derubertis, F. R., Melhem, M. (1997). Nitric oxide in diabetic nephropathy. Kidney Int. 52 [Suppl 60], S46-S53
|
30 |
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. I., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., McDaniel, M. L. (1992). Aminoguanidine, a novel inhibition of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41, 552-556
DOI
ScienceOn
|
31 |
Craven P. A., Studer R. K., Felder J., Phillips S., Derubertis F. R. (1997) Nitric oxide inhibition of transforming growth factorbeta and collagen synthesis in mesangial cells. Diabetes 46, 671-681
DOI
ScienceOn
|
32 |
Doi, T., Vlassara, H., Kirstein, M., Yamada, Y., Striker, G. E., Striker L. J. (1992). Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 89, 2873-2877
|
33 |
Giardino, I., Edelstein, D., Brownlee, M. (1996). BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J. Clin. Invest. 97, 1422-1428
DOI
|
34 |
Ha, H., Kamanna, V. S., Kirschenbaum, M. A., Kim, K. H. (1997) Role of glycated low density lipoprotein in mesangial extracellular matrix synthesis. Kidney Int. 52 [Suppl 60], S54-S59
|
35 |
Ha, H., Lee, S. H., Kim, K. H. (1997). Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor- and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells. J. Pharmacol. Exp. Ther. 281, 1457-1462
|
36 |
Harper, P. A., Robinson, J. M., Hoover, R. L., Wright, T. C., Karnovsky, M. J. (1984). Improved methods for culturing rat glomerular cells. Kidney Int. 26, 875-880
DOI
ScienceOn
|
37 |
Heby, O., Persson, L. (1990). Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem. Sci. 15, 153-158
DOI
ScienceOn
|
38 |
Lee, H. B., Cha, M. K., Song, K. I., Kim, J. H., Lee, E. Y., Kim, S. I., Kim, J., Yoo, M. H. (1997). Pathogenic role of advanced glycosylation end products in diabetic nephropathy. Kidney Int. 52 [Suppl 60], S60-S65
DOI
ScienceOn
|
39 |
Hoffman, B. B., Sharma, K., Zhu, Y., Ziyadeh, F. N. (1998). Transcriptional activation of transforming growth factor- mesangial cell culture by high glucose concentration. Kidney Int. 54, 1107-1116
DOI
ScienceOn
|
40 |
King, G. L., Ishii, H., Koya, D. (1997). Diabetic vascular dysfunction: A model of excess activation of protein kinase C. Kidney Int. 52 [Suppl 60], S77-S85
|
41 |
Makino, H., Shikata, K., Hironaka, K., Kushiro, M., Yamasaki, Y., Sugimoto H., Ota Z., Akari N., Horiuchi S. (1995). Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int. 48, 517-526
DOI
ScienceOn
|
42 |
Makita, Z., Vlassara, H., Cerami, A., Bucala, R. (1992). Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 267, 5133-5138
|
43 |
Mitsuhashi, T., Nakayama, H., Itoh, T., Kuwajima, S., Aoki, S., Atsumi, T., Koike, T. (1993). Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rats. Diabetes 42, 826-832
DOI
ScienceOn
|
44 |
Oh, J. H., Ha, H., Yu, M. R., Lee, H. B. (1998). Sequential effects of high glucose on mesangial cell transforming growth factor- and fibronectinin synthesis. Kidney Int. 54, 1872-1878
DOI
ScienceOn
|
45 |
Pricci, F., Pugliese, G., Mene, P., Romeo, G., Romano, G., Galli, G., Casini, A., Rotella, C. M., Mario U. D., Pugliese F. (1996). Regulatory role of eicosanoids in extracellular matrix overproduction induced by long-term exposure to high glucose in cultured rat mesangial cells. Diabetologia 39, 1055-1062
DOI
ScienceOn
|